These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 26205315)

  • 1. Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol.
    Wong A; Benedict NJ; Lohr BR; Pizon AF; Kane-Gill SL
    Drug Alcohol Depend; 2015 Sep; 154():296-9. PubMed ID: 26205315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome.
    Wong A; Benedict NJ; Armahizer MJ; Kane-Gill SL
    Ann Pharmacother; 2015 Jan; 49(1):14-9. PubMed ID: 25325907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of propofol-containing versus benzodiazepine regimens for alcohol withdrawal requiring mechanical ventilation.
    Sohraby R; Attridge RL; Hughes DW
    Ann Pharmacother; 2014 Apr; 48(4):456-61. PubMed ID: 24436457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome.
    Lee JA; Duby JJ; Cocanour CS
    Clin Toxicol (Phila); 2019 Jul; 57(7):624-627. PubMed ID: 30729859
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of Acute Alcohol Withdrawal Syndrome in Critically Ill Patients.
    Dixit D; Endicott J; Burry L; Ramos L; Yeung SY; Devabhakthuni S; Chan C; Tobia A; Bulloch MN
    Pharmacotherapy; 2016 Jul; 36(7):797-822. PubMed ID: 27196747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of phenobarbital monotherapy to a benzodiazepine-based regimen for management of alcohol withdrawal syndrome in trauma patients.
    Fleenor LM; Beavers JR; Tidwell WP; Atchison L; Woo E; Medvecz AJ; Beyene RT; Kast K; Marcovitz D; Dennis BM; Guillamondegui OD; Smith MC
    J Trauma Acute Care Surg; 2024 Mar; 96(3):493-498. PubMed ID: 37599414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Early Dexmedetomidine Addition to the Standard of Care for Severe Alcohol Withdrawal in the ICU: A Retrospective Controlled Cohort Study.
    VanderWeide LA; Foster CJ; MacLaren R; Kiser TH; Fish DN; Mueller SW
    J Intensive Care Med; 2016 Mar; 31(3):198-204. PubMed ID: 25326428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Severe Alcohol Withdrawal.
    Schmidt KJ; Doshi MR; Holzhausen JM; Natavio A; Cadiz M; Winegardner JE
    Ann Pharmacother; 2016 May; 50(5):389-401. PubMed ID: 26861990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal.
    Wong A; Benedict NJ; Kane-Gill SL
    J Crit Care; 2015 Apr; 30(2):405-9. PubMed ID: 25433725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.
    Moore PW; Donovan JW; Burkhart KK; Waskin JA; Hieger MA; Adkins AR; Wert Y; Haggerty DA; Rasimas JJ
    J Med Toxicol; 2014 Jun; 10(2):126-32. PubMed ID: 24619543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propofol for Treatment of Refractory Alcohol Withdrawal Syndrome: A Review of the Literature.
    Brotherton AL; Hamilton EP; Kloss HG; Hammond DA
    Pharmacotherapy; 2016 Apr; 36(4):433-42. PubMed ID: 26893017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive Use of Ketamine for Benzodiazepine-Resistant Severe Alcohol Withdrawal: a Retrospective Evaluation.
    Shah P; McDowell M; Ebisu R; Hanif T; Toerne T
    J Med Toxicol; 2018 Sep; 14(3):229-236. PubMed ID: 29748926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a symptom-triggered protocol approach to the management of alcohol withdrawal syndrome in older adults.
    Taheri A; Dahri K; Chan P; Shaw M; Aulakh A; Tashakkor A
    J Am Geriatr Soc; 2014 Aug; 62(8):1551-5. PubMed ID: 24962514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of resistant alcohol withdrawal (RAW): A retrospective case-control study.
    Benedict NJ; Wong A; Cassidy E; Lohr BR; Pizon AF; Smithburger PL; Falcione BA; Kirisci L; Kane-Gill SL
    Drug Alcohol Depend; 2018 Nov; 192():303-308. PubMed ID: 30308384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes After Implementation of a Benzodiazepine-Sparing Alcohol Withdrawal Order Set in an Integrated Health Care System.
    Smith JT; Sage M; Szeto H; Myers LC; Lu Y; Martinez A; Kipnis P; Liu VX
    JAMA Netw Open; 2022 Feb; 5(2):e220158. PubMed ID: 35191968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barbiturates for the treatment of alcohol withdrawal syndrome: A systematic review of clinical trials.
    Mo Y; Thomas MC; Karras GE
    J Crit Care; 2016 Apr; 32():101-7. PubMed ID: 26795441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill.
    Sen S; Grgurich P; Tulolo A; Smith-Freedman A; Lei Y; Gray A; Dargin J
    Ann Pharmacother; 2017 Feb; 51(2):101-110. PubMed ID: 27733668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol withdrawal syndrome in critically ill patients: protocolized versus nonprotocolized management.
    Duby JJ; Berry AJ; Ghayyem P; Wilson MD; Cocanour CS
    J Trauma Acute Care Surg; 2014 Dec; 77(6):938-43. PubMed ID: 25248063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.